Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-10 Sale | 2021-02-12 6:36 pm | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 8,400 | $25.3 | $212,555 | 10,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Option Award | 2024-04-03 8:47 pm | N/A 2034-03-31 | Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer | 300,638 | $0 | 343,249 (Direct) | View |
Ownership | 2024-02-08 7:26 pm | N/A N/A | Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer | 0 | $0 | 42,611 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 4:28 pm | N/A 2034-01-18 | MARINUS PHARMACEUTICALS INC. | MRNS | Noonberg Sarah B. Director | 25,500 | $0 | 32,700 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 6:56 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | Noonberg Sarah B. Director | 15,400 | $0 | 15,400 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:26 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-16 Option Award | 2023-05-17 9:08 pm | N/A 2033-05-16 | MARINUS PHARMACEUTICALS INC. | MRNS | Noonberg Sarah B. Director | 39,600 | $0 | 39,600 (Direct) | View |
| 2023-01-16 Option Award | 2023-01-18 8:03 pm | N/A 2033-01-15 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:01 pm | N/A 2032-05-26 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 6:24 pm | N/A 2032-05-11 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 6:43 pm | N/A 2031-05-26 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-05-11 Option Award | 2021-05-13 5:37 pm | N/A 2031-05-10 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:36 pm | N/A 2028-05-28 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 8,400 | $0 | 10,900 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 6:36 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 8,400 | $6.98 | 10,900 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 6:16 pm | N/A 2030-05-27 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-05 Option Award | 2020-05-07 4:26 pm | N/A 2030-05-05 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:45 pm | N/A 2029-10-09 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-11 6:28 pm | N/A 2029-06-06 | Protagonist Therapeutics Inc | PTGX | Noonberg Sarah B. Director | 12,000 | $0 | 12,000 (Direct) | View |